Biopharmaceutical benchmarks 2010.
Walsh
Gary
G
Industrial Biochemistry Program, Department of Chemical and Environmental Sciences, Materials and Surface Science Institute, University of Limerick, Limerick City, Ireland. gary.walsh@ul.ie
D018033:Antibodies, Bispecific / Q000191:economics / Q000627:therapeutic use; D019985:Benchmarking / Q000592:standards*; D001688:Biological Products / Q000191:economics; D001702:Biopharmaceutics / Q000191:economics / Q000592:standards*; D019496:Cancer Vaccines / Q000191:economics; D017277:Drug Approval / Q000706:statistics & numerical data; D004345:Drug Industry / Q000191:economics / Q000592:standards; D016568:Drugs, Generic / Q000191:economics; D005060:Europe; D040541:Marketing / Q000191:economics; D015202:Protein Engineering / Q000191:economics; D014481:United States
D018033:Antibodies, Bispecific; D001688:Biological Products; D019496:Cancer Vaccines; D016568:Drugs, Generic